Ocugen, Inc. (OCGN)
1.375
+0.08
(+5.77%)
USD |
NASDAQ |
Dec 12, 16:00
1.365
-0.01
(-0.73%)
After-Hours: 20:00
Ocugen Research and Development Expense (TTM): 35.49M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Belite Bio, Inc. | 38.01M |
| MannKind Corp. | 49.90M |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| CorMedix, Inc. | 12.46M |
| Verastem, Inc. | 103.74M |